Download by
Scanning QR Code
No Stock Yet
Yunnan Baiyao: Senior Vice President Wang Jin Resigns for Personal Reasons
The “demining” behind the 100 billion Yunnan Baiyao leadership change continues
“Investor Network” Cai Jun In March of this year, Yunnan Baiyao Group Co., Ltd. (“Yunnan Baiyao”, 000538.SZ) announced that Chairman Wang Minghui resigned due to personal reasons. According to the structure, Yunnan Baiyao previously had Chairman Wang Minghui and Co-Chairman Chen Fashu. Both were over 60 years old. According to data, Wang Minghui has been the company's chairman since 2004. During this period, the company continued to grow and successfully reached its peak through the toothpaste brand. Wang Minghui's departure represents the entry of Yunnan Baiyao into a new chapter. Currently, the CEO performs the position of chairman on his behalf. Afterwards, the company will convene a board of directors to complete the appointment of the new director
Yunnan Baiyao Chairman Steps Down; Shares Fall 4%
01:17 AM EST, 03/07/2023 (MT Newswires) -- Wang Minghui resigned as chairman of Yunnan Baiyao Group (SHE:000538), effective immediately, the traditional Chinese medicine producer said Tuesday. Wang ho
Yunnan Baiyao: Chairman Wang Minghui resigns due to personal reasons
Yunnan Baiyao (000538.SZ): Chairman Wang Minghui resigns
Gelonhui March 6 丨 Yunnan Baiyao (000538.SZ) announced that the 10th board of directors of the company recently received the “Resignation Report” from the company's chairman Wang Minghui. Wang Minghui applied for personal reasons to resign as chairman, director, board strategy committee member of the company's 10th board of directors, and all positions in Yunnan Baiyao and its holding subsidiaries. The resignation application took effect from the day it was served on the board of directors. The company's board of directors will complete the by-election of directors, the election of a new chairman, and the adjustment of the personnel of the special committee as soon as possible. Jointly recommended by more than half of the directors of the board of directors, before the board of directors elects a new chairman, the government will
Yunnan Baiyao (000538.SZ): Regarding securities investment, strictly control the scale of investment in the secondary market, gradually reduce positions, and do not continue to increase holdings
Gelonhui, Feb. 16 丨 Yunnan Baiyao (000538.SZ) recently said in an institutional survey that with regard to securities investment, the company strictly controls the scale of investment in the secondary market, gradually reduces positions, and does not continue to increase holdings through market analysis and research, after careful verification and review of the company's investment decision process, based on the original risk control measures, on the basis of the original risk control measures.
Yunnan Baiyao (000538.SZ): Anti-prolapse product Yang Yuanqing has been fully rolled out online and offline channels
Gelonhui, Feb. 16 丨 Yunnan Baiyao (000538.SZ) recently stated during an agency survey that the Yangyuanqing shampoo series includes shampoo and anti-hair loss lotion. Yang Yuanqing continues to position itself as a “scalp health management expert” as its brand, adapting to the increasing youthfulness of people with hair loss, using oil control shampoo and anti-hair loss shampoo with natural medicinal plant active ingredients, as the core product after 5 years of careful development, and extensive online and offline channels to open up global marketing links. During the double 11 period of 2022, Yang Yuanqing also took first place on Tmall's domestic goods anti-hair loss circuit.
Yunnan Baiyao: The construction of the company's medical and aesthetic clinics in Shanghai and Beijing is progressing steadily
Yunnan Baiyao: Launching Baiyao Solution for Sports Health Food
Noon announcement
Gelonhui January 18 丨 ① Yunnan Baiyao: “Patchouli Spray” with Yunnan Provincial Hospital of Traditional Chinese Medicine as the applicant and Yunnan Baiyao as the formulation configuration unit obtained the “Medical Institution Formulation Registration Approval” issued by the Yunnan Drug Administration. After review, this product complied with the relevant requirements for the registration of clinical research data for medical institutions formulations and approved the registration of this product with conditions. The product can be used in the recovery period of COVID-19 and symptoms related to wind chills; during the same period, the company received the “Drug GMP Compliance Test Results” approved and issued by the Yunnan Pharmaceutical Administration “Notice”. After review, the company's spray complies with “Pharmaceuticals” Production quality management specifications (2)
Loading...
No Stock Yet